Literature DB >> 20530002

Regulatory T cells protect mice against coxsackievirus-induced myocarditis through the transforming growth factor beta-coxsackie-adenovirus receptor pathway.

Yu Shi1, Masahiro Fukuoka, Guohua Li, Youan Liu, Manyin Chen, Michael Konviser, Xin Chen, Mary Anne Opavsky, Peter P Liu.   

Abstract

BACKGROUND: Coxsackievirus B3 infection is an excellent model of human myocarditis and dilated cardiomyopathy. Cardiac injury is caused either by a direct cytopathic effect of the virus or through immune-mediated mechanisms. Regulatory T cells (Tregs) play an important role in the negative modulation of host immune responses and set the threshold of autoimmune activation. This study was designed to test the protective effects of Tregs and to determine the underlying mechanisms. METHODS AND
RESULTS: Carboxyfluorescein diacetate succinimidyl ester-labeled Tregs or naïve CD4(+) T cells were injected intravenously once every 2 weeks 3 times into mice. The mice were then challenged with intraperitoneal coxsackievirus B3 immediately after the last cell transfer. Transfer of Tregs showed higher survival rates than transfer of CD4(+) T cells (P=0.0136) but not compared with the PBS injection group (P=0.0589). Interestingly, Tregs also significantly decreased virus titers and inflammatory scores in the heart. Transforming growth factor-beta and phosphorylated AKT were upregulated in Tregs-transferred mice and coxsackie-adenovirus receptor expression was decreased in the heart compared with control groups. Transforming growth factor-beta decreased coxsackie-adenovirus receptor expression and inhibited coxsackievirus B3 infection in HL-1 cells and neonatal cardiac myocytes. Splenocytes collected from Treg-, CD4(+) T-cell-, and PBS-treated mice proliferated equally when stimulated with heat-inactivated virus, whereas in the Treg group, the proliferation rate was reduced significantly when stimulated with noninfected heart tissue homogenate.
CONCLUSIONS: Adoptive transfer of Tregs protected mice from coxsackievirus B3-induced myocarditis through the transforming growth factor beta-coxsackie-adenovirus receptor pathway and thus suppresses the immune response to cardiac tissue, maintaining the antiviral immune response.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20530002     DOI: 10.1161/CIRCULATIONAHA.109.893248

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  48 in total

1.  Susceptibility to autoimmune myocarditis is associated with intrinsic differences in CD4(+) T cells.

Authors:  P Chen; G C Baldeviano; D L Ligons; M V Talor; J G Barin; N R Rose; D Cihakova
Journal:  Clin Exp Immunol       Date:  2012-08       Impact factor: 4.330

2.  Inhibition of microRNA-155 ameliorates experimental autoimmune myocarditis by modulating Th17/Treg immune response.

Authors:  Lianhua Yan; Fen Hu; Xiaofei Yan; Yuzhen Wei; Wenhan Ma; Ya Wang; Shuai Lu; Zhaohui Wang
Journal:  J Mol Med (Berl)       Date:  2016-04-06       Impact factor: 4.599

Review 3.  Cardiac Autoimmunity: Myocarditis.

Authors:  William Bracamonte-Baran; Daniela Čiháková
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

Review 4.  Heart Failure with Preserved Ejection Fraction and Future Pharmacological Strategies: a Glance in the Crystal Ball.

Authors:  Carsten Tschöpe; Sophie Van Linthout; Behrouz Kherad
Journal:  Curr Cardiol Rep       Date:  2017-08       Impact factor: 2.931

Review 5.  Heart Inflammation: Immune Cell Roles and Roads to the Heart.

Authors:  Francisco J Carrillo-Salinas; Njabulo Ngwenyama; Marina Anastasiou; Kuljeet Kaur; Pilar Alcaide
Journal:  Am J Pathol       Date:  2019-05-18       Impact factor: 4.307

6.  Protective and detrimental roles for regulatory T cells in a viral model for multiple sclerosis.

Authors:  Nicholas E Martinez; Fridrik Karlsson; Fumitaka Sato; Eiichiro Kawai; Seiichi Omura; Alireza Minagar; Matthew B Grisham; Ikuo Tsunoda
Journal:  Brain Pathol       Date:  2014-02-25       Impact factor: 6.508

7.  Regulatory T cells and Th17 cells in viral infections: implications for multiple sclerosis and myocarditis.

Authors:  Nicholas E Martinez; Fumitaka Sato; Eiichiro Kawai; Seiichi Omura; Robert P Chervenak; Ikuo Tsunoda
Journal:  Future Virol       Date:  2012-06       Impact factor: 1.831

Review 8.  Myocarditis.

Authors:  Sandeep Sagar; Peter P Liu; Leslie T Cooper
Journal:  Lancet       Date:  2011-12-18       Impact factor: 79.321

9.  VEGF165 attenuates the Th17/Treg imbalance that exists when transplanting allogeneic skeletal myoblasts to treat acute myocardial infarction.

Authors:  Ruijun Liu; Changfa Guo; Chen Yang; Demin Xu; Chunsheng Wang
Journal:  Inflamm Res       Date:  2012-09-21       Impact factor: 4.575

10.  TLR3 deficiency induces chronic inflammatory cardiomyopathy in resistant mice following coxsackievirus B3 infection: role for IL-4.

Authors:  Eric D Abston; Michael J Coronado; Adriana Bucek; Jennifer A Onyimba; Jessica E Brandt; J Augusto Frisancho; Eunyong Kim; Djahida Bedja; Yoon-kyu Sung; Andrea J Radtke; Kathleen L Gabrielson; Wayne Mitzner; DeLisa Fairweather
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-12-19       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.